Payment overview · 2025
General Payments
$271.79
8 reported records · 3 companies
Healthcare provider profile · identity verified
Scott C Scoggins, MD
Allopathic & Osteopathic Physicians|Family Medicine · FORT MYERS, FL · NPI 1699771014
Verified facts
What the public records show
CMS Open Payments records show Scott C Scoggins, MD received $271.79 in general payments during 2025 across 8 reported records.
Amgen Inc. accounted for 86.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 125 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 26 claims for Rybelsus by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $234.68 | 86.3% | 6 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $20.76 | 7.6% | 1 | 2025 |
| Merck Sharp & Dohme LLC | Unresolved — no canonical attribution shown | $16.35 | 6.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $271.79 | 8 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $186.79 | 4 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $66.22 | 3 | 2025 |
Source payment records
|
|||||
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $47.89 | 2 | 2025 |
Source payment records
|
|||||
| PROLIA Normalized: prolia |
Biological | Amgen Inc. | $23.30 | 1 | 2025 |
Source payment records
|
|||||
| CAPVAXIVE Normalized: capvaxive |
Biological | Merck Sharp & Dohme LLC | $16.35 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
125 | 21 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
26 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 684 | 171 |
| Levothyroxine Sodium | Levothyroxine Sodium | 527 | 134 |
| Amlodipine Besylate | Amlodipine Besylate | 516 | 143 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 493 | 85 |
| Omeprazole | Omeprazole | 461 | 136 |
| Alprazolam | Alprazolam | 460 | 55 |
| Lisinopril | Lisinopril | 430 | 111 |
| Losartan Potassium | Losartan Potassium | 430 | 116 |
| Pantoprazole Sodium | Pantoprazole Sodium | 428 | 116 |
| Furosemide | Furosemide | 380 | 96 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 319 | 44 |
| Sertraline Hcl | Sertraline Hcl | 308 | 68 |
| Gabapentin | Gabapentin | 299 | 78 |
| Tramadol Hcl | Tramadol Hcl | 282 | 58 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 274 | 81 |
| Metoprolol Succinate | Metoprolol Succinate | 269 | 71 |
| Clonazepam | Clonazepam | 259 | 36 |
| Glimepiride | Glimepiride | 234 | 51 |
| Tizanidine Hcl | Tizanidine Hcl | 227 | 41 |
| Lorazepam | Lorazepam | 224 | 38 |
| Pregabalin | Pregabalin | 214 | 36 |
| Trazodone Hcl | Trazodone Hcl | 211 | 53 |
| Tamsulosin Hcl | Tamsulosin Hcl | 201 | 51 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 187 | 46 |
| Montelukast Sodium | Montelukast Sodium | 179 | 49 |
| Pravastatin Sodium | Pravastatin Sodium | 177 | 45 |
| Metformin Hcl | Metformin Hcl | 176 | 47 |
| Potassium Chloride | Potassium Chloride | 174 | 48 |
| Spironolactone | Spironolactone | 174 | 36 |
| Simvastatin | Simvastatin | 170 | 47 |
| Eliquis | Apixaban | 169 | 30 |
| Famotidine | Famotidine | 167 | 44 |
| Zolpidem Tartrate | Zolpidem Tartrate | 167 | 33 |
| Metoprolol Tartrate | Metoprolol Tartrate | 165 | 38 |
| Oxycodone Hcl | Oxycodone Hcl | 164 | 22 |
| Carvedilol | Carvedilol | 159 | 36 |
| Fluticasone Propionate | Fluticasone Propionate | 150 | 46 |
| Meloxicam | Meloxicam | 142 | 34 |
| Mirtazapine | Mirtazapine | 142 | 32 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 141 | 25 |
| Citalopram Hbr | Citalopram Hydrobromide | 135 | 38 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 135 | 27 |
| Diazepam | Diazepam | 132 | 15 |
| Prednisone | Prednisone | 130 | 64 |
| Ropinirole Hcl | Ropinirole Hcl | 128 | 36 |
| Clopidogrel | Clopidogrel Bisulfate | 125 | 32 |
| Ozempic | Semaglutide | 125 | 21 |
| Hydrochlorothiazide | Hydrochlorothiazide | 124 | 31 |
| Aripiprazole | Aripiprazole | 123 | 18 |
| Duloxetine Hcl | Duloxetine Hcl | 121 | 31 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 121 | 34 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 120 | 29 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 119 | 26 |
| Bupropion Xl | Bupropion Hcl | 117 | 31 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 107 | 28 |
| Diclofenac Sodium | Diclofenac Sodium | 101 | 19 |
| Mounjaro | Tirzepatide | 100 | 16 |
| Fluoxetine Hcl | Fluoxetine Hcl | 98 | 24 |
| Quetiapine Fumarate | Quetiapine Fumarate | 92 | 16 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 90 | 24 |
| Estradiol | Estradiol | 88 | 25 |
| Promethazine Hcl | Promethazine Hcl | 88 | 14 |
| Celecoxib | Celecoxib | 85 | 23 |
| Symbicort | Budesonide/Formoterol Fumarate | 82 | 16 |
| Ondansetron Hcl | Ondansetron Hcl | 80 | 15 |
| Topiramate | Topiramate | 80 | 20 |
| Jardiance | Empagliflozin | 77 | 20 |
| Warfarin Sodium | Warfarin Sodium | 76 | 15 |
| Azithromycin | Azithromycin | 75 | 65 |
| Donepezil Hcl | Donepezil Hcl | 74 | 20 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 74 | 14 |
| Allopurinol | Allopurinol | 70 | 22 |
| Metformin Hcl Er | Metformin Hcl | 67 | 17 |
| Ondansetron Odt | Ondansetron | 66 | 11 |
| Testosterone Cypionate | Testosterone Cypionate | 65 | 17 |
| Mupirocin | Mupirocin | 64 | 25 |
| Baclofen | Baclofen | 63 | 12 |
| Ezetimibe | Ezetimibe | 63 | 13 |
| Propranolol Hcl | Propranolol Hcl | 63 | 16 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 61 | 14 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 60 | 14 |
| Trulicity | Dulaglutide | 58 | 14 |
| Atenolol | Atenolol | 57 | 19 |
| Buspirone Hcl | Buspirone Hcl | 57 | 14 |
| Linzess | Linaclotide | 57 | 13 |
| Amitriptyline Hcl | Amitriptyline Hcl | 55 | 14 |
| Benazepril Hcl | Benazepril Hcl | 55 | 13 |
| Paroxetine Hcl | Paroxetine Hcl | 54 | 19 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 51 | 14 |
| Finasteride | Finasteride | 50 | 13 |
| Advair Hfa | Fluticasone Propion/Salmeterol | 49 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 49 | 17 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 46 | 12 |
| Clobetasol Propionate | Clobetasol Propionate | 45 | 11 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 45 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 44 | suppressed |
| Novolog Flexpen | Insulin Aspart | 44 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 41 | 20 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 40 | 11 |
| Fluconazole | Fluconazole | 39 | 21 |
| Valacyclovir | Valacyclovir Hcl | 39 | 17 |
| Januvia | Sitagliptin Phosphate | 37 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 37 | suppressed |
| Synthroid | Levothyroxine Sodium | 37 | suppressed |
| Cephalexin | Cephalexin | 36 | 23 |
| Farxiga | Dapagliflozin Propanediol | 36 | suppressed |
| Myrbetriq | Mirabegron | 35 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 35 | 14 |
| Lamotrigine | Lamotrigine | 34 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 34 | 22 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 33 | suppressed |
| Ibuprofen | Ibuprofen | 33 | 12 |
| Invokana | Canagliflozin | 33 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 32 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 32 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 32 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 31 | 11 |
| Nystatin | Nystatin | 31 | 14 |
| Torsemide | Torsemide | 31 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 30 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 30 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 30 | 11 |
| Lovastatin | Lovastatin | 30 | suppressed |
| Chlorthalidone | Chlorthalidone | 28 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 28 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 27 | suppressed |
| Methocarbamol | Methocarbamol | 27 | 12 |
| Olanzapine | Olanzapine | 27 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 27 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 26 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 26 | suppressed |
| Rybelsus | Semaglutide | 26 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 25 | suppressed |
| Glipizide Er | Glipizide | 25 | suppressed |
| Levemir Flexpen | Insulin Detemir | 25 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 24 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 24 | suppressed |
| Ketoconazole | Ketoconazole | 23 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 22 | suppressed |
| Premarin | Estrogens, Conjugated | 22 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 22 | suppressed |
| Xarelto | Rivaroxaban | 22 | suppressed |
| Bumetanide | Bumetanide | 21 | suppressed |
| Irbesartan | Irbesartan | 21 | suppressed |
| Valsartan | Valsartan | 21 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 20 | 18 |
| Klor-Con M20 | Potassium Chloride | 20 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Nifedipine Er | Nifedipine | 20 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 19 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 19 | 12 |
| Alendronate Sodium | Alendronate Sodium | 18 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 18 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 18 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 18 | 11 |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 18 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 18 | suppressed |
| Tirosint | Levothyroxine Sodium | 18 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 18 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 17 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 17 | suppressed |
| Memantine Hcl | Memantine Hcl | 17 | suppressed |
| Penicillin V Potassium | Penicillin V Potassium | 17 | suppressed |
| Ubrelvy | Ubrogepant | 17 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 16 | suppressed |
| Fentanyl | Fentanyl | 16 | suppressed |
| Levetiracetam | Levetiracetam | 16 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 15 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 15 | suppressed |
| Glipizide | Glipizide | 15 | suppressed |
| Lamotrigine Er | Lamotrigine | 15 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 15 | suppressed |
| Savella | Milnacipran Hcl | 15 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Fenofibrate | Fenofibrate | 14 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 14 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 14 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 13 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 13 | suppressed |
| Temazepam | Temazepam | 13 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 12 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 12 | suppressed |
| Digoxin | Digoxin | 12 | suppressed |
| Eszopiclone | Eszopiclone | 12 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 12 | suppressed |
| Lidocaine | Lidocaine | 12 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 12 | suppressed |
| Ranolazine Er | Ranolazine | 12 | suppressed |
| Tramadol Hcl Er | Tramadol Hcl | 12 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Vraylar | Cariprazine Hcl | 12 | suppressed |
| Colchicine | Colchicine | 11 | suppressed |
| Estradiol (Twice Weekly) | Estradiol | 11 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 11 | suppressed |
| Ibu | Ibuprofen | 11 | suppressed |
| Methadone Hcl | Methadone Hcl | 11 | suppressed |
| Metolazone | Metolazone | 11 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 11 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 11 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $271.79 · 8 records | Amgen Inc. | CAPVAXIVE, EVENITY, OTEZLA, PROLIA, REPATHA | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error